Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1979 1
1980 1
1983 1
1987 1
1988 1
1990 1
1992 2
1993 3
1994 3
1995 7
1996 10
1997 13
1998 22
1999 33
2000 43
2001 46
2002 56
2003 63
2004 66
2005 61
2006 63
2007 50
2008 49
2009 40
2010 52
2011 44
2012 47
2013 43
2014 38
2015 29
2016 35
2017 28
2018 27
2019 30
2020 26
2021 32
2022 38
2023 18
2024 15
2025 36
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,084 results

Results by year

Filters applied: . Clear all
Page 1
Homocysteine in Chronic Kidney Disease.
Ostrakhovitch EA, Tabibzadeh S. Ostrakhovitch EA, et al. Adv Clin Chem. 2015;72:77-106. doi: 10.1016/bs.acc.2015.07.002. Epub 2015 Aug 24. Adv Clin Chem. 2015. PMID: 26471081 Review.
Hyperhomocysteinemia occurs in chronic- and end-stage kidney disease at the time when dialysis or transplant becomes indispensable for survival. ...Here, we review mechanisms of redox regulation and show how cysteinyl modifications triggered by excess Hcy con …
Hyperhomocysteinemia occurs in chronic- and end-stage kidney disease at the time when dialysis or transplant becomes in …
The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.
Angelini A, Cappuccilli ML, Magnoni G, Croci Chiocchini AL, Aiello V, Napoletano A, Iacovella F, Troiano A, Mancini R, Capelli I, Cianciolo G. Angelini A, et al. G Ital Nefrol. 2021 Aug 30;38(4):2021-vol4. G Ital Nefrol. 2021. PMID: 34469084 Free article. Review.
Patients with chronic kidney disease or end-stage renal disease experience tremendous cardiovascular risk. ...Hyperhomocysteinemia is commonly found in CKD patients because of impaired renal metabolism and reduced renal excretion. …
Patients with chronic kidney disease or end-stage renal disease experience tremendous cardiovascular risk …
A Meta-Analysis of the Effects of Homocysteine-Lowering Therapy on Chronic Kidney Disease.
Lin H, Liu Y, Geng S, Sun Y, Li X, Li B, Liu Y. Lin H, et al. Horm Metab Res. 2026 Jan;58(1):13-22. doi: 10.1055/a-2780-5656. Epub 2026 Jan 30. Horm Metab Res. 2026. PMID: 41617174
Hyperhomocysteinemia is common in chronic kidney disease; however, whether homocysteine-lowering therapy slows chronic kidney disease progression remains uncertain. ...Subgroup analyses suggested a greater benefit in participants w …
Hyperhomocysteinemia is common in chronic kidney disease; however, whether homocysteine-lowering therapy slows …
Vitamin B12 and chronic kidney disease.
Wu HHL, Wang AY. Wu HHL, et al. Vitam Horm. 2022;119:325-353. doi: 10.1016/bs.vh.2022.01.011. Epub 2022 Feb 25. Vitam Horm. 2022. PMID: 35337625
Chronic Kidney Disease (CKD) is an emerging public health issue with a fast-growing global prevalence. ...Hyperhomocysteinemia is frequently observed in CKD and End-Stage Kidney Disease (ESKD), but its representation as a prognostic marker for C …
Chronic Kidney Disease (CKD) is an emerging public health issue with a fast-growing global prevalence. ...Hyperhomocyst …
Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
van Guldener C, Nanayakkara PW, Stehouwer CD. van Guldener C, et al. Clin Chem Lab Med. 2007;45(12):1683-7. doi: 10.1515/CCLM.2007.340. Clin Chem Lab Med. 2007. PMID: 17937610 Review.
Hyperhomocysteinemia has been associated with an increased risk of cardiovascular disease in end-stage renal disease, especially in patients without malnutrition and inflammation. ...So far, homocysteine-lowering therapy has not been very successful in …
Hyperhomocysteinemia has been associated with an increased risk of cardiovascular disease in end-stage renal disease, e …
Serum concentration of homocysteine in spontaneous feline chronic kidney disease.
Giraldi M, Paltrinieri S, Curcio C, Scarpa P. Giraldi M, et al. Vet J. 2019 Dec;254:105358. doi: 10.1016/j.tvjl.2019.105358. Epub 2019 Aug 22. Vet J. 2019. PMID: 31836166 Free article.
Serum homocysteine (Hcy) increases in people and dogs with chronic kidney disease (CKD). Hyperhomocysteinemia (HHcy) has also been associated with CKD-related hypertension and proteinuria. ...HHcy was relatively common in cats with advanced CKD and see …
Serum homocysteine (Hcy) increases in people and dogs with chronic kidney disease (CKD). Hyperhomocysteinemia (H …
Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study.
Shen Z, Zhang Z, Zhao W. Shen Z, et al. BMC Nephrol. 2022 Dec 31;23(1):419. doi: 10.1186/s12882-022-03045-6. BMC Nephrol. 2022. PMID: 36587192 Free PMC article.
AIMS: This cross-sectional study aimed to investigate the association between plasma homocysteine (Hcy) and chronic kidney disease (CKD) in US patients with type 2 diabetes mellitus (T2DM). ...Compared to patients with normal Hcy, those with HHcy were …
AIMS: This cross-sectional study aimed to investigate the association between plasma homocysteine (Hcy) and chronic kidney …
Association of hyperhomocysteinemia and chronic kidney disease in the general population: a systematic review and meta-analysis.
Chen W, Feng J, Ji P, Liu Y, Wan H, Zhang J. Chen W, et al. BMC Nephrol. 2023 Aug 23;24(1):247. doi: 10.1186/s12882-023-03295-y. BMC Nephrol. 2023. PMID: 37612681 Free PMC article.
BACKGROUND: Increasing evidence shows that an elevated homocysteine(Hcy) level is associated with an increased risk of chronic kidney disease (CKD). This study systematically evaluated the correlation between homocysteine level and the incidence …
BACKGROUND: Increasing evidence shows that an elevated homocysteine(Hcy) level is associated with an increased risk of chronic …
Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME, Lindholm B, Bárány P, Qureshi AR, Stenvinkel P. Suliman ME, et al. Semin Dial. 2007 Nov-Dec;20(6):523-9. doi: 10.1111/j.1525-139X.2007.00336.x. Semin Dial. 2007. PMID: 17991198 Review.
The homocysteine (Hcy) theory states that total homocysteine (tHcy) is a risk factor for atherosclerosis. Chronic kidney disease (CKD) is one of the most frequent causes of hyperhomocysteinemia in the presence of high prevalence of cardiovascula …
The homocysteine (Hcy) theory states that total homocysteine (tHcy) is a risk factor for atherosclerosis. Chronic ki …
1,084 results